On May 23, Igor Vasilyev, the head of the Kirov region, launched a new production facility at the site of biotech cluster owned by Vostok LLC. The enterprise began to produce Polyphepan pharmaceutical substance and Polyphepan medicinal products in the form of powder, granules and tablets.
In 2016, the company acquired the exclusive right to manufacture Polyphepan pharmaceutical substance and Polyphepan medicinal products in the form of powder, granules and tablets. Polyphepan is a natural sorbent that is used for treatment of intoxication, gastric disorders, and is several times more effective than activated carbon. The product is obtained through the process of hydrolysis at the Kirov Biochemical Plant. At the Vostok facility, this substance is processed into a ready-to-use product (such as bioactive additives and animal feed additives) and packaged. The planned output is up to 20 tons per month.
With the opening of this new production facility, Vostok LLC will create about a dozen new jobs.